|
0
|
|
Rebinding drives cellular retention of small-molecule drugs with abundant targets.
(pnas.org)
|
Li B
…
Mitchison TJ
PNAS
2026-05-26
|
#pharmacokinetics
#modeling
#cancer
#drug retention
|
|
0
|
|
Light-controlled disruption of cancer cell dormancy via photoswitchable stress hormone receptor degraders.
(pnas.org)
|
Freitag KM
…
Gapp K
PNAS
2026-05-26
|
#cancer
#protein degradation
#dormancy
#protac
#photopharmacology
|
|
0
|
|
Chemical biology tools for studying histone post-translational modifications.
(linkinghub.elsevier.com)
|
Douglas CJ
…
Seath CP
Cell Chemical Biology
2026-05-26
|
#chromatin
#cancer
#gene expression
#post-translational-modifications
#chemical biology
|
|
0
|
|
Molecular architecture of the tumor microenvironment caused by BRCA1 and BRCA2 somatic mutations in human lung adenocarcinoma.
(elifesciences.org)
|
Liao G
…
Xu G
eLife
2026-05-26
|
#immunity
#transcriptomics
#cancer
#sequencing
#immunotherapy
|
|
0
|
|
A BCG hydrogel enables localized NOD2/STING activation to overcome resistance to immune checkpoint blockade.
(pnas.org)
|
Xiao Z
…
Qiao H
PNAS
2026-05-26
|
#immunity
#cancer
#inflammation
#immunotherapy
#macrophage
|
|
0
|
|
NRF2 activation by myeloid cell-derived oxidative stress induces SNAI-driven features of EMT in breast cancer.
(pnas.org)
|
Kaya M
…
Martner A
PNAS
2026-05-26
|
#cancer
#inflammation
#oxidative stress
#metastasis
#emt
|
|
0
|
|
Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity.
(pnas.org)
|
Geng X
…
Rao L
PNAS
2026-05-26
|
#cancer
#immunotherapy
#protease
#nanovesicles
#glycocalyx
|
|
0
|
|
Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myeloma.
(pnas.org)
|
Jiang L
…
Chen SJ
PNAS
2026-05-26
|
#immunity
#transcriptomics
#cancer
#sequencing
#clustering
|